The Asia Pacific Centre for Animal Health (APCAH) is an internationally focused research and research training centre that aims to optimise animal production and product quality through improved control of infectious agents.
The Centre conducts multidisciplinary research to develop fundamental understanding of the epidemiology and pathogenesis of infectious diseases of animals and applies this to enhancing control of disease through improved strategies for vaccination, diagnosis and management. Our expertise extends across the full range of production animal species (cattle, sheep, poultry and pigs), as well as companion animal species (dogs, cats and horses) and wildlife.
Among the achievements of the Centre are the development of novel diagnostic antigens for serological diagnosis of mycoplasmosis in poultry and pigs, and the development of novel vaccines to control disease caused by Mycoplasma gallisepticum, Mycoplasma synoviae, Mycoplasma hyopneumoniae, Mycoplasma bovis, chicken anaemia virus and infectious laryngotracheitis virus. The mycoplasma vaccines developed by the Centre are marketed under the trade names Vaxsafe MG, Vaxsafe MS and Vaxsafe MHP. Our vaccines against M. bovis, chicken anaemia virus and infectious laryngotracheitis virus are currently being evaluated by commercial collaborators.
We are part of the NHMRC National Centre of Excellence in Antimicrobial Stewardship (NCAS), with the aim of optimising the use of antimicrobial therapy in production and companion animals.
In addition to discovery-based research, APCAH also conducts contract research for the development and registration of novel animal health products to international standards and provides microbiological diagnostic services.